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Abstract 
 
Background: Cheong-Hwa-Bo-Um-Tang (CHB) has been traditionally used to treat pharyngolaryngitis and throat inflammation in 
Korea. However, the anti-inflammatory activity of CHB and the exact component proportion ratio of CHB have not been fully 
reported.  
Materials and Methods: This study was conducted to optimize the component proportion ratio of CHB on the basis of experimental 
evidence using multiplex cytokine profiling assay in LPS-stimulated RAW 264.7 mouse macrophages.  
Results: The optimized CHB (named Chunhwabun-Cheong-Hwa-Bo-Um-Tang) inhibited the production of NO, IL-6, MCP-1, GM-
CSF, IL-10, IP-10, VEGF, M-CSF, RANTES, MIP-1β, LIF, LIX, and TNF-α in LPS-stimulated RAW 264.7 mouse macrophages 
without decreasing cell viability (P<0.05). Chunhwabun-Cheong-Hwa-Bo-Um-Tang consisted of roots of Scrophularia buergeriana, 
Trichosanthes kirilowii, Anemarrhena asphodeloides, Phellodendron amurense, Angelica gigas, Rehmannia glutinosa, Paeonia 
japonica, Cnidium officinale, and Glycyrrhiza uralensis (in the ratio of 8: 3: 3: 3: 3: 4: 4: 3: 3).  
Conclusion: The results of this study indicate that the multiplex cytokine profiling assay could be one of the effective methods for 
evidence-guided optimization of the component proportion ratio of a traditional herbal formula used for treating excessive 
inflammation such as the cytokine storm. 
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Introduction 
 
Differential use of cellular and molecular components shapes immune responses, but understanding of how these are 
regulated to promote defense and health during infections is still incomplete (Kallal and Biron, 2013). Innate immune responses are 
evolutionarily conserved processes that provide crucial protection against invading organisms (Dantoft et al., 2013). The 
inflammasome, an intracellular multiprotein complex, has emerged as playing a key role in innate immunity (Im and Ammit, 2014).  
Recent studies have identified the critical role of inflammasome activation in host defense and inflammation (Yuk and Jo, 
2013). Inflammation, the process aimed at restoring homeostasis after an insult, can be more damaging than the insult itself if 
uncontrolled, excessive, or prolonged (dos Santos et al., 2012). Uncontrolled inflammation leads to extensive tissue damage and 
manifestation of pathological states like sepsis, autoimmune diseases, metabolic diseases, and cancer (Lacatus 2013). 
Cytokines are known to control the initiation, perpetuation, execution, and resolution of an immune response, which 
involves temporally and spatially orchestrated interactions between different immune cells (Ilangumaran et al., 2004). Although 
chemokines, chemotactic cytokines that control the migratory patterns and positioning of all immune cells, were initially appreciated 
as important mediators of acute inflammation, it is suggested that this complex system of approximately 50 endogenous chemokine 
ligands and 20 G protein-coupled seven-transmembrane signaling receptors is also critical for the generation of primary and 
secondary adaptive cellular and humoral immune responses (Griffith et al., 2014). 
Cells of the innate immune system detect pathogen-associated molecular patterns or endogenous molecules released as a 
result of tissue injury or inflammation through various innate immune receptors, collectively termed pattern-recognition receptors 
(Ibrahim et al., 2013). 
Macrophages play an important role in inflammatory disease through the release of factors such as nitric oxide (NO), 
reactive oxygen species, intracellular calcium, inflammatory cytokines, chemokines, growth factors, prostaglandin mediators, and 
transcription factors involved in the immune response to pathogens such as bacteria and viruses (Medina et al., 2010). 
Lipopolysaccharide (LPS) is a potent bacterial effector triggering the activation of the innate immune system following 
binding with the complex CD14, myeloid differentiation protein 2, and Toll-like receptor 4 (Paciello et al., 2013). 
A traditional herbal formula, Cheong-Hwa-Bo-Um-Tang (CHB), which was introduced in Donguibogam, has been used to 
treat pharyngolaryngitis and throat inflammation in Korea. However, the anti-inflammatory activity of CHB and the exact 
component proportion ratio of CHB have not been fully reported.  
This study was conducted to optimize the component proportion ratio of CHB on the basis of experimental evidence using 
multiplex cytokine profiling assay in LPS-induced RAW 264.7 mouse macrophages.  
 
 
Materials and Methods 
Materials 
 
  DMEM, FBS, penicillin, streptomycin, PBS, and other tissue culture reagents were purchased from Gibco BRL (Grand 
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Island, NY, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), indomethacin, Griess reagent, and all other 
chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). The multiplex bead-based cytokine assay kits used for the 
determination of cytokine concentration were purchased from Millipore (Billerica, MA, USA). 
 
 
 
Cell Viability Assay 
 
RAW 264.7 mouse macrophages were obtained from the Korea Cell Line Bank (Seoul, Korea). RAW 264.7 cells were 
cultured in DMEM supplemented with 10% FBS containing 100 U/mL of penicillin and 100 µg/mL of streptomycin at 37°C in a 5% 
CO2 humidified incubator. Cell viability was evaluated with the modified MTT assay. 
 
Preparation of CCH, GCH, SCH, and LCH Derived from CHB 
 
CHB has been reported to consist of roots of Scrophularia buergeriana, Trichosanthes kirilowii, Anemarrhena 
asphodeloides, Phellodendron amurense, Angelica gigas, Rehmannia glutinosa, Paeonia japonica, Cnidium officinale, and 
Glycyrrhiza uralensis. But the component proportion ratio of CHB has been differently reported in traditional medical classics. 
Hence, firstly, four kinds of herbal formulae derived from CHB were prepared on the basis of traditional medical classics and 
articles. These four herbal formulae are Chunhwabun-Cheong-Hwa-Bo-Um-Tang (CCH), Guaruin-Cheong-Hwa-Bo-Um-Tang 
(GCH), Hwangkeum-Cheong-Hwa-Bo-Um-Tang (SCH), and Indongdeung-Cheong-Hwa-Bo-Um-Tang (LCH). The compositions of 
CCH, GCH, SCH, and LCH are shown in TABLE 1. All herbs were obtained from Omniherb (Daegu, Korea) and deposited at the 
Department of Pathology, College of Korean Medicine, Gachon University. Because herbal formulae have been traditionally 
extracted using water, in the present study, CCH, GCH, SCH, and LCH were extracted with boiling water for 2 hr, filtered, and then 
lyophilized (yield: 38.44% ; 35.63% ; 32.12% ; 29.2%, respectively). The powdered extract was dissolved in saline and then filtered 
through a 0.22 µm syringe filter. 
 
Quantification of NO Production 
 
NO concentration in culture medium was determined by the Griess reaction assay. Specifically, after incubation of cells 
with materials for 24 hr, 100 µL of the supernatant from each well was mixed with 100 µL of Griess reagent in wells of a 96-well 
plate. After incubation for 15 min at room temperature, OD was determined at 540 nm with a microplate reader (Bio-Rad, Hercules, 
CA, USA). 
 
CCH GCH SCH LCH
Root of Scrophularia buergeriana 8 8 6 6
Root of Trichosanthes kirilowi 3 3 3
Semen of Trichosanthes kirilowi 3
Root of Anemarrhena asphodeloides 3 3 3 3
Root of Phelledendron amurense 3 3 4 4
Root of Angelica gigas 3 3 2 2
Root of Rehmannia glutinosa 4 4 4 4
Root of Paeonia japonica 4 4 2 2
Root of Cnidium officinale 3 3 2 2
Root of Glycyrrhiza uralensis 3 3 3 3
Root of Scutellaria baicalensis 4
Root of Coptis chinensis 3
Stem of Lonicera japonica 3
Herbal medicines
Ratio
TABLE 1: The contents of CCH, GCH, SCH, and LCH
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Multiplex Bead-Based Cytokine Assay 
 
After 24 hr treatment with materials, cytokines released by treated cells were measured in cell culture supernatants using 
a Luminex assay based on xMAP technology. This assay was performed using Milliplex kits (Millipore) and Bio-Plex 200 
suspension array system (Bio-Rad) as described previously (Yoon et al., 2009; Yuk et al., 2010). Standard curves for each cytokine 
were generated using the kit-supplied reference cytokine samples. Production of the following cytokines was analyzed: interleukin 
(IL)-6, IL-10, interferon inducible protein-10 (IP-10), granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage 
colony-stimulating factor (GM-CSF), leukemia inhibitory factor (LIF; IL-6 class cytokine), lipopolysaccharide-induced CXC 
chemokine (LIX; CXCL5), macrophage colony-stimulating factor (M-CSF), monocyte chemotactic protein (MCP)-1, macrophage 
inflammatory protein (MIP)-1α, MIP-1β, MIP-2, RANTES/CCL5, tumor necrosis factor (TNF)-α, and vascular endothelial growth 
factor (VEGF). 
 
Statistical Analysis 
 
The results presented are summarized from three independent experiments and are expressed as the mean ± SD. 
Significant differences were examined using a Student’s t-test with SPSS 11.0 software (SPSS, Chicago, IL, USA). In all cases, a P 
value < 0.05 was considered statistically significant. 
 
 
Results  
Effects of CCH, GCH, SCH, and LCH on Cell Viability 
 
Cell viability of RAW 264.7 mouse macrophages in the presence of CCH, GCH, SCH, and LCH is shown in Figure 1. 
Cytotoxicity of these formula extracts (up to a concentration of 200µg/mL) was not obvious after 24 hr incubation. Based on this 
result, concentrations of these formula extracts up to 200µg/mL were chosen for subsequent experiments. 
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Figure 1: Effects of CCH, GCH, SCH, and LCH on cell viability of RAW 264.7 mouse macrophages. After 24 hr treatment, cell 
viability was evaluated by a modified MTT assay. Normal group (Nor) was treated with media only. IN denotes indomethacin (0.5 
µM). Values are expressed as the mean ± SD of more than three independent experiments. 
 
 
Effects of CCH, GCH, SCH, and LCH on NO Production 
 
The effects of CCH, GCH, SCH, and LCH on NO production in LPS-stimulated RAW 264.7 mouse macrophages are 
shown in Figure 2. Both CCH and LCH significantly decreased NO production in LPS-stimulated RAW 264.7 mouse macrophages 
at concentrations of 25, 50, 100, and 200µg/mL, whereas SCH significantly decreased NO production at concentrations of 25 and 
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200 µg/mL. GCH significantly decreased NO production at a concentration of 50µg/mL. 
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Figure 2: Effects of CCH, GCH, SCH, and LCH on NO production in LPS-stimulated RAW 264.7 mouse macrophages. After 24 hr 
treatment, NO production was evaluated by Griess reagent assay. Normal group (Nor) was treated with media only. Control group 
(Con) was treated with LPS (1 µg/mL) only. IN denotes indomethacin (0.5 µM). Values are expressed as the mean ± SD of more 
than three independent experiments. * P < 0.05 vs. Con; ** P < 0.01; *** P < 0.001. 
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Figure 3: Effects of CCH on production of cytokines such as IL-6, MCP-1, GM-CSF, IL-10, IP-10, LIF, LIX, TNF-α, VEGF, M-
CSF, MIP-1β, and RANTES in LPS-stimulated RAW 264.7 mouse macrophages. Flourescene intensity of each cytokine in the 
culture medium was measured by a Multiplex bead-based cytokine assay after 24 hr incubation. Normal group (Nor) was treated 
with media only. Control group (Con) was treated with LPS (1 µg/mL) alone. IN denotes indomethacin (0.5 µM). Values are 
expressed as the mean ± SD of more than three independent experiments. * P < 0.05 vs. Con; ** P < 0.01; *** P < 0.001. 
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Figure 4: Effects of GCH on production of cytokines such as IL-6, MCP-1, GM-CSF, IL-10, IP-10, LIF, LIX, TNF-α, VEGF, MIP-2, 
MIP-1β, and RANTES in LPS-stimulated RAW 264.7 mouse macrophages. Flourescene intensity of each cytokine in the culture 
medium was measured by a Multiplex bead-based cytokine assay after 24 hr incubation. Normal group (Nor) was treated with media 
only. Control group (Con) was treated with LPS (1 µg/mL) alone. IN denotes indomethacin (0.5 µM). Values are expressed as the 
mean ± SD of more than three independent experiments. * P < 0.05 vs. Con; ** P < 0.01. 
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Figure 5: Effects of SCH on production of cytokines such as IL-6, GM-CSF, VEGF, LIX, LIF, M-CSF, TNF-α, G-CSF, MIP-1α, 
MIP-1β, MIP-2, and RANTES in LPS-stimulated RAW 264.7 mouse macrophages. Flourescene intensity of each cytokine in the 
culture medium was measured by a Multiplex bead-based cytokine assay after 24 hr incubation. Normal group (Nor) was treated 
with media only. Control group (Con) was treated with LPS (1 µg/mL) alone. IN denotes indomethacin (0.5 µM). Values are 
expressed as the mean ± SD of three independent experiments. * P < 0.05 vs. Con; ** P < 0.01. 
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Figure 6: Effects of LCH on production of cytokines such as IL-6, GM-CSF, VEGF, LIX, LIF, M-CSF, TNF-α, G-CSF, MIP-1α, 
MIP-1β, MIP-2, and RANTES in LPS-stimulated RAW 264.7 mouse macrophages. Flourescene intensity of each cytokine in the 
culture medium was measured by a Multiplex bead-based cytokine assay after 24 hr incubation. Normal group (Nor) was treated 
with media only. Control group (Con) was treated with LPS (1 µg/mL) alone. IN denotes indomethacin (0.5 µM). Values are 
expressed as the mean ± SD of three independent experiments. * P < 0.05 vs. Con; ** P < 0.01; *** P < 0.001. 
 
 
Discussion 
 
 Physical barriers along with immune defense systems which have evolved to protect the host from microbial invasion and 
acute inflammation is a response to infection or cellular disturbances by other means such as trauma (Bauernfeind and Hornung, 
2013). But the uncontrolled inflammatory phenomena could be a turning point for the development of acute or chronic inflammatory 
diseases (dos Santos et al., 2012). Among the many immuno-inflammatory leukocytes, macrophages and monocytes are of great 
importance (Kang et al., 2010). 
Macrophages play a central role in the inflammatory response and serve as an essential interface between innate and 
adaptive immunity by modulating NO, various cytokines, prostaglandins, calcium, and hydrogen peroxide (Maruotti et al., 2007). 
NO is a major component in the host innate immune reaction to various pathogens including bacteria, viruses, fungi, and 
other parasites (Bogdan et al., 2000). Hernansanz-Agustín et al. have also reported that, in the immune system, NO has been mainly 
associated with antibacterial defenses exerted through oxidative, nitrosative, and nitrative stress and signal transduction through 
cyclic GMP-dependent mechanisms (Hernansanz-Agustin et al., 2013). But excessive NO production is related to the development 
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of septic shock, neuropathological diseases, rheumatoid arthritis (RA), and other autoimmune disorders (O'Shea et al., 2002). 
Cytokines are small proteins which play important roles in cell signaling and they are secreted by a variety of cellular 
sources acting either on the cell producing them (autocrine) or on the surrounding cells (paracrine) (Burska et al., 2014). Cytokines 
also control the initiation, perpetuation, execution, and resolution of an immune response, which involves temporally and spatially 
orchestrated interactions between different immune cells (Ilangumaran et al., 2004).  
However, excessive and uncontrolled production of inflammatory mediators such as cytokines, NO, and PGE2 may lead to 
not only autoimmune disorders but also serious systemic complications such as microcirculatory dysfunction, tissue damage, and 
septic shock with a resulting high mortality (Schoettler and Brahn, 2009; Ulevitch and Tobias, 1995). 
Schultzberg et al. have already reported that the activation of microglia and astrocytes with subsequent release of cytokines 
and other inflammatory factors such as NO are common features of both acute and chronic neurodegenerative disorders (Schultzberg 
et al., 2007). 
Hu et al. reported that the dysregulation of inflammatory/immune responses in sepsis is responsible for multiple organ 
failure, for which overexpression of pro-inflammatory cytokines (i.e. cytokine storm) is a major mechanism (Hu et al., 2014). It is 
well known that both viral and bacterial infections contribute to the pathogenesis of severe sepsis, which is characterized by an 
overwhelming production of NO and proinflammatory cytokines, such as IL-1 and IL-6 (Ulloa and Tracey, 2005). Despite the recent 
discovery of antibiotics, sepsis remains a clinical challenge, with high mortality rates and increasing prevalence (Sessler and 
Shepherd, 2002). 
Ballara et al. have suggested that increased levels of IL-6, TNF-α, and VEGF often correlate with several inflammatory 
autoimmune diseases including RA, systemic-onset juvenile chronic arthritis, osteoporosis, psoriasis, polyclonal plasmacytosis, 
malignant plasmacytoma, Crohn’s disease, and experimental autoimmune encephalomyelitis (Ballara et al., 2001). It has already 
been demonstrated that LIX/CXCL5 expression in bone cells has implications for inflammatory bone diseases such as arthritis and 
periodontal disease (Ruddy et al., 2004). 
Recently, it has been reported by Srivastava et al. that various chemokines such as MCP-1, M-CSF, G-CSF, GM-CSF, and 
IP-10 are increased in bronchoalveolar fluid and the lung tissue of pneumococcal pneumonia during lung inflammation (Srivastava 
et al., 2005). Wareing et al. have also suggested that the expression level of MIP-1α, MIP-1β, MIP-2, and RANTES is increased in 
lung tissue after influenza infection (Wareing et al., 2004). 
IL-10, although traditionally considered as an anti-inflammatory cytokine that modulates the function of adaptive immune-
related cells, has also been implicated in promoting abnormal angiogenesis in the eye and in the pathobiology of autoimmune 
diseases such as lupus and encephalomyelitis (Dace et al., 2009). In psoriasis, a chronic immune-mediated skin disease, the central 
role of cytokines and their functional interaction with adhesion molecules in the recruitment of tissue-specific lymphocytes has been 
clearly shown, mainly involving IL-10 and LIF (Schon and Boehncke, 2005). With respect to asthma, a chronic inflammatory 
disease of the airway, it has already been reported that bronchial epithelial cell changes in asthma are induced by LIF which 
promotes the expression of  neurokinin-1 receptor, and JAK/STAT pathway and MAPK/ERK pathway may participate in the 
process (Hu et al., 2006). 
There is an increasing interest in herbal drugs especially for the treatment of various inflammatory diseases (Hsieh et al., 
2008). As a traditional herbal formula, CHB has been used to treat pharyngolaryngitis and throat inflammation in Korea. However, 
the anti-inflammatory activity of CHB and the exact component proportion ratio of CHB have not been fully reported. 
This study was conducted to optimize the component proportion ratio of CHB on the basis of experimental evidence using 
multiplex cytokine profiling assay in LPS-stimulated RAW 264.7 cells. 
Initially, four kinds of herbal formulae (CCH, GCH, SCH, and LCH) derived from CHB were prepared on the basis of 
traditional medical text and articles. Multiplex assay with MTT and Griess assay was performed to evaluate the anti-inflammatory 
activity of these formulae. Among these four formulae, CCH turned out to be the most effective formula which significantly 
inhibited the production of inflammatory mediators such as NO, IL-6, MCP-1, GM-CSF, IL-10, IP-10, VEGF, M-CSF, RANTES, 
MIP-1β, LIF, LIX, and TNF-α without decreasing cell viability in LPS-stimulated RAW 264.7 cells. GCH was found to significantly 
inhibit the production of IP-10, RANTES, IL-10, and MIP-1β, whereas SCH was found to significantly inhibit the production of NO, 
IL-6, GM-CSF, VEGF, LIX, and M-CSF in LPS- stimulated RAW 264.7 cells. LCH significantly inhibited the production of NO, IL-
6, GM-CSF, and LIX in LPS-stimulated RAW 264.7 cells. 
In conclusion, the current study demonstrates that CCH has an anti-inflammatory property related to the inhibition of NO, 
IL-6, MCP-1, GM-CSF, IL-10, IP-10, VEGF, M-CSF, RANTES, MIP-1β, LIF, LIX, and TNF-α in LPS-stimulated RAW 264.7 
mouse macrophages without decreasing cell viability. The actual effect of CCH in acute and chronic inflammatory diseases deserves 
further study. The multiplex cytokine profiling assay may be one of the effective methods for evidence-guided optimization of the 
component proportion ratio of a traditional herbal formula used for treating excessive inflammation such as the cytokine storm. 
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